nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—ESR1—Tamoxifen—pancreatic cancer	0.239	0.447	CbGbCtD
Danazol—CYP19A1—Tamoxifen—pancreatic cancer	0.194	0.362	CbGbCtD
Danazol—CYP3A4—Tamoxifen—pancreatic cancer	0.0245	0.0459	CbGbCtD
Danazol—CYP3A4—Erlotinib—pancreatic cancer	0.0209	0.039	CbGbCtD
Danazol—CYP3A4—Irinotecan—pancreatic cancer	0.0188	0.0352	CbGbCtD
Danazol—CYP3A4—Docetaxel—pancreatic cancer	0.0138	0.0258	CbGbCtD
Danazol—CYP3A4—Sunitinib—pancreatic cancer	0.0137	0.0257	CbGbCtD
Danazol—CYP3A4—Doxorubicin—pancreatic cancer	0.0103	0.0193	CbGbCtD
Danazol—Oedema—Sunitinib—pancreatic cancer	0.000467	0.00199	CcSEcCtD
Danazol—Constipation—Tamoxifen—pancreatic cancer	0.000466	0.00198	CcSEcCtD
Danazol—Alopecia—Gemcitabine—pancreatic cancer	0.000466	0.00198	CcSEcCtD
Danazol—Fatigue—Erlotinib—pancreatic cancer	0.000465	0.00198	CcSEcCtD
Danazol—Constipation—Erlotinib—pancreatic cancer	0.000461	0.00196	CcSEcCtD
Danazol—Shock—Sunitinib—pancreatic cancer	0.000459	0.00196	CcSEcCtD
Danazol—Alopecia—Fluorouracil—pancreatic cancer	0.000458	0.00195	CcSEcCtD
Danazol—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000457	0.00195	CcSEcCtD
Danazol—Back pain—Irinotecan—pancreatic cancer	0.000456	0.00194	CcSEcCtD
Danazol—Muscle spasms—Irinotecan—pancreatic cancer	0.000453	0.00193	CcSEcCtD
Danazol—Back pain—Gemcitabine—pancreatic cancer	0.000444	0.00189	CcSEcCtD
Danazol—Fluid retention—Doxorubicin—pancreatic cancer	0.000441	0.00188	CcSEcCtD
Danazol—Urticaria—Tamoxifen—pancreatic cancer	0.000433	0.00184	CcSEcCtD
Danazol—Body temperature increased—Erlotinib—pancreatic cancer	0.000426	0.00182	CcSEcCtD
Danazol—Weight increased—Docetaxel—pancreatic cancer	0.000425	0.00181	CcSEcCtD
Danazol—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000425	0.00181	CcSEcCtD
Danazol—Vision blurred—Fluorouracil—pancreatic cancer	0.000425	0.00181	CcSEcCtD
Danazol—Vertigo—Irinotecan—pancreatic cancer	0.000423	0.0018	CcSEcCtD
Danazol—Syncope—Irinotecan—pancreatic cancer	0.000422	0.0018	CcSEcCtD
Danazol—Leukopenia—Irinotecan—pancreatic cancer	0.000422	0.0018	CcSEcCtD
Danazol—Paraesthesia—Sunitinib—pancreatic cancer	0.000419	0.00178	CcSEcCtD
Danazol—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000417	0.00178	CcSEcCtD
Danazol—Photosensitivity—Epirubicin—pancreatic cancer	0.000415	0.00177	CcSEcCtD
Danazol—Loss of consciousness—Irinotecan—pancreatic cancer	0.000414	0.00176	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000413	0.00176	CcSEcCtD
Danazol—Dyspepsia—Sunitinib—pancreatic cancer	0.000411	0.00175	CcSEcCtD
Danazol—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000411	0.00175	CcSEcCtD
Danazol—Leukopenia—Gemcitabine—pancreatic cancer	0.000411	0.00175	CcSEcCtD
Danazol—Myocardial infarction—Docetaxel—pancreatic cancer	0.000408	0.00174	CcSEcCtD
Danazol—Hypertension—Irinotecan—pancreatic cancer	0.000407	0.00173	CcSEcCtD
Danazol—Jaundice—Docetaxel—pancreatic cancer	0.000406	0.00173	CcSEcCtD
Danazol—Leukopenia—Fluorouracil—pancreatic cancer	0.000404	0.00172	CcSEcCtD
Danazol—Fatigue—Sunitinib—pancreatic cancer	0.000402	0.00171	CcSEcCtD
Danazol—Constipation—Sunitinib—pancreatic cancer	0.000399	0.0017	CcSEcCtD
Danazol—Hypertension—Gemcitabine—pancreatic cancer	0.000396	0.00169	CcSEcCtD
Danazol—Asthenia—Tamoxifen—pancreatic cancer	0.000391	0.00167	CcSEcCtD
Danazol—Convulsion—Fluorouracil—pancreatic cancer	0.000391	0.00166	CcSEcCtD
Danazol—Arthralgia—Gemcitabine—pancreatic cancer	0.000391	0.00166	CcSEcCtD
Danazol—Asthenia—Erlotinib—pancreatic cancer	0.000387	0.00165	CcSEcCtD
Danazol—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000386	0.00164	CcSEcCtD
Danazol—Pruritus—Tamoxifen—pancreatic cancer	0.000385	0.00164	CcSEcCtD
Danazol—Oedema—Irinotecan—pancreatic cancer	0.000384	0.00164	CcSEcCtD
Danazol—Photosensitivity—Doxorubicin—pancreatic cancer	0.000384	0.00164	CcSEcCtD
Danazol—Pruritus—Erlotinib—pancreatic cancer	0.000381	0.00162	CcSEcCtD
Danazol—Shock—Irinotecan—pancreatic cancer	0.000378	0.00161	CcSEcCtD
Danazol—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000376	0.0016	CcSEcCtD
Danazol—Haemoglobin—Docetaxel—pancreatic cancer	0.000376	0.0016	CcSEcCtD
Danazol—Oedema—Gemcitabine—pancreatic cancer	0.000374	0.0016	CcSEcCtD
Danazol—Haemorrhage—Docetaxel—pancreatic cancer	0.000374	0.00159	CcSEcCtD
Danazol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000372	0.00158	CcSEcCtD
Danazol—Body temperature increased—Sunitinib—pancreatic cancer	0.000369	0.00157	CcSEcCtD
Danazol—Oedema—Fluorouracil—pancreatic cancer	0.000368	0.00157	CcSEcCtD
Danazol—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000367	0.00156	CcSEcCtD
Danazol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000362	0.00154	CcSEcCtD
Danazol—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00036	0.00154	CcSEcCtD
Danazol—Visual impairment—Docetaxel—pancreatic cancer	0.00036	0.00154	CcSEcCtD
Danazol—Dizziness—Tamoxifen—pancreatic cancer	0.00036	0.00153	CcSEcCtD
Danazol—Tachycardia—Fluorouracil—pancreatic cancer	0.000359	0.00153	CcSEcCtD
Danazol—Migraine—Epirubicin—pancreatic cancer	0.000359	0.00153	CcSEcCtD
Danazol—Affect lability—Epirubicin—pancreatic cancer	0.000359	0.00153	CcSEcCtD
Danazol—Dizziness—Erlotinib—pancreatic cancer	0.000356	0.00152	CcSEcCtD
Danazol—Erythema multiforme—Docetaxel—pancreatic cancer	0.000354	0.00151	CcSEcCtD
Danazol—Flushing—Docetaxel—pancreatic cancer	0.000347	0.00148	CcSEcCtD
Danazol—Vomiting—Tamoxifen—pancreatic cancer	0.000346	0.00148	CcSEcCtD
Danazol—Mood swings—Epirubicin—pancreatic cancer	0.000345	0.00147	CcSEcCtD
Danazol—Paraesthesia—Irinotecan—pancreatic cancer	0.000345	0.00147	CcSEcCtD
Danazol—Rash—Tamoxifen—pancreatic cancer	0.000344	0.00146	CcSEcCtD
Danazol—Dermatitis—Tamoxifen—pancreatic cancer	0.000343	0.00146	CcSEcCtD
Danazol—Vomiting—Erlotinib—pancreatic cancer	0.000343	0.00146	CcSEcCtD
Danazol—Headache—Tamoxifen—pancreatic cancer	0.000341	0.00145	CcSEcCtD
Danazol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000341	0.00145	CcSEcCtD
Danazol—Rash—Erlotinib—pancreatic cancer	0.00034	0.00145	CcSEcCtD
Danazol—Dermatitis—Erlotinib—pancreatic cancer	0.00034	0.00145	CcSEcCtD
Danazol—Dyspepsia—Irinotecan—pancreatic cancer	0.000338	0.00144	CcSEcCtD
Danazol—Headache—Erlotinib—pancreatic cancer	0.000338	0.00144	CcSEcCtD
Danazol—Paraesthesia—Gemcitabine—pancreatic cancer	0.000336	0.00143	CcSEcCtD
Danazol—Chills—Docetaxel—pancreatic cancer	0.000336	0.00143	CcSEcCtD
Danazol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000335	0.00143	CcSEcCtD
Danazol—Asthenia—Sunitinib—pancreatic cancer	0.000335	0.00143	CcSEcCtD
Danazol—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000333	0.00142	CcSEcCtD
Danazol—Affect lability—Doxorubicin—pancreatic cancer	0.000332	0.00141	CcSEcCtD
Danazol—Migraine—Doxorubicin—pancreatic cancer	0.000332	0.00141	CcSEcCtD
Danazol—Fatigue—Irinotecan—pancreatic cancer	0.000331	0.00141	CcSEcCtD
Danazol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000331	0.00141	CcSEcCtD
Danazol—Alopecia—Docetaxel—pancreatic cancer	0.000331	0.00141	CcSEcCtD
Danazol—Pruritus—Sunitinib—pancreatic cancer	0.00033	0.00141	CcSEcCtD
Danazol—Constipation—Irinotecan—pancreatic cancer	0.000329	0.0014	CcSEcCtD
Danazol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000324	0.00138	CcSEcCtD
Danazol—Nausea—Tamoxifen—pancreatic cancer	0.000324	0.00138	CcSEcCtD
Danazol—Fatigue—Gemcitabine—pancreatic cancer	0.000323	0.00138	CcSEcCtD
Danazol—Constipation—Gemcitabine—pancreatic cancer	0.00032	0.00136	CcSEcCtD
Danazol—Nausea—Erlotinib—pancreatic cancer	0.00032	0.00136	CcSEcCtD
Danazol—Mood swings—Doxorubicin—pancreatic cancer	0.00032	0.00136	CcSEcCtD
Danazol—Back pain—Docetaxel—pancreatic cancer	0.000315	0.00134	CcSEcCtD
Danazol—Muscle spasms—Docetaxel—pancreatic cancer	0.000313	0.00133	CcSEcCtD
Danazol—Eosinophilia—Epirubicin—pancreatic cancer	0.000312	0.00133	CcSEcCtD
Danazol—Pancreatitis—Epirubicin—pancreatic cancer	0.000309	0.00132	CcSEcCtD
Danazol—Dizziness—Sunitinib—pancreatic cancer	0.000309	0.00131	CcSEcCtD
Danazol—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000308	0.00131	CcSEcCtD
Danazol—Body temperature increased—Irinotecan—pancreatic cancer	0.000304	0.00129	CcSEcCtD
Danazol—Vomiting—Sunitinib—pancreatic cancer	0.000297	0.00126	CcSEcCtD
Danazol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000296	0.00126	CcSEcCtD
Danazol—Rash—Sunitinib—pancreatic cancer	0.000294	0.00125	CcSEcCtD
Danazol—Dermatitis—Sunitinib—pancreatic cancer	0.000294	0.00125	CcSEcCtD
Danazol—Urticaria—Fluorouracil—pancreatic cancer	0.000292	0.00125	CcSEcCtD
Danazol—Headache—Sunitinib—pancreatic cancer	0.000292	0.00125	CcSEcCtD
Danazol—Syncope—Docetaxel—pancreatic cancer	0.000292	0.00124	CcSEcCtD
Danazol—Leukopenia—Docetaxel—pancreatic cancer	0.000291	0.00124	CcSEcCtD
Danazol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000291	0.00124	CcSEcCtD
Danazol—Eosinophilia—Doxorubicin—pancreatic cancer	0.000289	0.00123	CcSEcCtD
Danazol—Palpitations—Docetaxel—pancreatic cancer	0.000288	0.00123	CcSEcCtD
Danazol—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000288	0.00123	CcSEcCtD
Danazol—Weight increased—Epirubicin—pancreatic cancer	0.000287	0.00122	CcSEcCtD
Danazol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000286	0.00122	CcSEcCtD
Danazol—Pancreatitis—Doxorubicin—pancreatic cancer	0.000286	0.00122	CcSEcCtD
Danazol—Convulsion—Docetaxel—pancreatic cancer	0.000282	0.0012	CcSEcCtD
Danazol—Hypertension—Docetaxel—pancreatic cancer	0.000281	0.0012	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000279	0.00119	CcSEcCtD
Danazol—Arthralgia—Docetaxel—pancreatic cancer	0.000277	0.00118	CcSEcCtD
Danazol—Nausea—Sunitinib—pancreatic cancer	0.000277	0.00118	CcSEcCtD
Danazol—Asthenia—Irinotecan—pancreatic cancer	0.000276	0.00117	CcSEcCtD
Danazol—Jaundice—Epirubicin—pancreatic cancer	0.000274	0.00117	CcSEcCtD
Danazol—Sweating—Epirubicin—pancreatic cancer	0.000269	0.00115	CcSEcCtD
Danazol—Asthenia—Gemcitabine—pancreatic cancer	0.000269	0.00114	CcSEcCtD
Danazol—Haematuria—Epirubicin—pancreatic cancer	0.000268	0.00114	CcSEcCtD
Danazol—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000266	0.00113	CcSEcCtD
Danazol—Oedema—Docetaxel—pancreatic cancer	0.000266	0.00113	CcSEcCtD
Danazol—Weight increased—Doxorubicin—pancreatic cancer	0.000265	0.00113	CcSEcCtD
Danazol—Pruritus—Gemcitabine—pancreatic cancer	0.000265	0.00113	CcSEcCtD
Danazol—Shock—Docetaxel—pancreatic cancer	0.000261	0.00111	CcSEcCtD
Danazol—Pruritus—Fluorouracil—pancreatic cancer	0.00026	0.00111	CcSEcCtD
Danazol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00026	0.00111	CcSEcCtD
Danazol—Tachycardia—Docetaxel—pancreatic cancer	0.000259	0.0011	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000258	0.0011	CcSEcCtD
Danazol—Dizziness—Irinotecan—pancreatic cancer	0.000254	0.00108	CcSEcCtD
Danazol—Haemoglobin—Epirubicin—pancreatic cancer	0.000254	0.00108	CcSEcCtD
Danazol—Jaundice—Doxorubicin—pancreatic cancer	0.000253	0.00108	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—pancreatic cancer	0.000252	0.00107	CcSEcCtD
Danazol—Sweating—Doxorubicin—pancreatic cancer	0.000249	0.00106	CcSEcCtD
Danazol—Haematuria—Doxorubicin—pancreatic cancer	0.000248	0.00106	CcSEcCtD
Danazol—Vomiting—Irinotecan—pancreatic cancer	0.000244	0.00104	CcSEcCtD
Danazol—Dizziness—Fluorouracil—pancreatic cancer	0.000243	0.00104	CcSEcCtD
Danazol—Visual impairment—Epirubicin—pancreatic cancer	0.000243	0.00104	CcSEcCtD
Danazol—Rash—Irinotecan—pancreatic cancer	0.000242	0.00103	CcSEcCtD
Danazol—Dermatitis—Irinotecan—pancreatic cancer	0.000242	0.00103	CcSEcCtD
Danazol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000242	0.00103	CcSEcCtD
Danazol—Headache—Irinotecan—pancreatic cancer	0.000241	0.00103	CcSEcCtD
Danazol—Paraesthesia—Docetaxel—pancreatic cancer	0.000239	0.00102	CcSEcCtD
Danazol—Erythema multiforme—Epirubicin—pancreatic cancer	0.000239	0.00102	CcSEcCtD
Danazol—Vomiting—Gemcitabine—pancreatic cancer	0.000238	0.00101	CcSEcCtD
Danazol—Rash—Gemcitabine—pancreatic cancer	0.000236	0.00101	CcSEcCtD
Danazol—Dermatitis—Gemcitabine—pancreatic cancer	0.000236	0.001	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—pancreatic cancer	0.000235	0.000999	CcSEcCtD
Danazol—Headache—Gemcitabine—pancreatic cancer	0.000235	0.000999	CcSEcCtD
Danazol—Flushing—Epirubicin—pancreatic cancer	0.000234	0.000997	CcSEcCtD
Danazol—Vomiting—Fluorouracil—pancreatic cancer	0.000234	0.000997	CcSEcCtD
Danazol—Dyspepsia—Docetaxel—pancreatic cancer	0.000234	0.000996	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—pancreatic cancer	0.000233	0.000994	CcSEcCtD
Danazol—Rash—Fluorouracil—pancreatic cancer	0.000232	0.000989	CcSEcCtD
Danazol—Dermatitis—Fluorouracil—pancreatic cancer	0.000232	0.000988	CcSEcCtD
Danazol—Headache—Fluorouracil—pancreatic cancer	0.000231	0.000982	CcSEcCtD
Danazol—Fatigue—Docetaxel—pancreatic cancer	0.000229	0.000976	CcSEcCtD
Danazol—Nausea—Irinotecan—pancreatic cancer	0.000228	0.000973	CcSEcCtD
Danazol—Constipation—Docetaxel—pancreatic cancer	0.000227	0.000968	CcSEcCtD
Danazol—Chills—Epirubicin—pancreatic cancer	0.000226	0.000964	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—pancreatic cancer	0.000225	0.000958	CcSEcCtD
Danazol—Alopecia—Epirubicin—pancreatic cancer	0.000223	0.00095	CcSEcCtD
Danazol—Nausea—Gemcitabine—pancreatic cancer	0.000222	0.000947	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000221	0.00094	CcSEcCtD
Danazol—Nausea—Fluorouracil—pancreatic cancer	0.000219	0.000932	CcSEcCtD
Danazol—Flushing—Doxorubicin—pancreatic cancer	0.000217	0.000923	CcSEcCtD
Danazol—Tension—Epirubicin—pancreatic cancer	0.000216	0.000918	CcSEcCtD
Danazol—Nervousness—Epirubicin—pancreatic cancer	0.000213	0.000909	CcSEcCtD
Danazol—Back pain—Epirubicin—pancreatic cancer	0.000212	0.000905	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—pancreatic cancer	0.000211	0.000899	CcSEcCtD
Danazol—Body temperature increased—Docetaxel—pancreatic cancer	0.00021	0.000895	CcSEcCtD
Danazol—Chills—Doxorubicin—pancreatic cancer	0.000209	0.000892	CcSEcCtD
Danazol—Vision blurred—Epirubicin—pancreatic cancer	0.000207	0.000882	CcSEcCtD
Danazol—Alopecia—Doxorubicin—pancreatic cancer	0.000206	0.000879	CcSEcCtD
Danazol—Tension—Doxorubicin—pancreatic cancer	0.000199	0.000849	CcSEcCtD
Danazol—Nervousness—Doxorubicin—pancreatic cancer	0.000197	0.000841	CcSEcCtD
Danazol—Vertigo—Epirubicin—pancreatic cancer	0.000197	0.00084	CcSEcCtD
Danazol—Syncope—Epirubicin—pancreatic cancer	0.000197	0.000839	CcSEcCtD
Danazol—Leukopenia—Epirubicin—pancreatic cancer	0.000197	0.000837	CcSEcCtD
Danazol—Back pain—Doxorubicin—pancreatic cancer	0.000197	0.000837	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000195	0.000832	CcSEcCtD
Danazol—Palpitations—Epirubicin—pancreatic cancer	0.000194	0.000827	CcSEcCtD
Danazol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000193	0.000822	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—pancreatic cancer	0.000192	0.000816	CcSEcCtD
Danazol—Asthenia—Docetaxel—pancreatic cancer	0.000191	0.000812	CcSEcCtD
Danazol—Convulsion—Epirubicin—pancreatic cancer	0.00019	0.000811	CcSEcCtD
Danazol—Hypertension—Epirubicin—pancreatic cancer	0.00019	0.000808	CcSEcCtD
Danazol—Pruritus—Docetaxel—pancreatic cancer	0.000188	0.000801	CcSEcCtD
Danazol—Arthralgia—Epirubicin—pancreatic cancer	0.000187	0.000796	CcSEcCtD
Danazol—Anxiety—Epirubicin—pancreatic cancer	0.000186	0.000794	CcSEcCtD
Danazol—Vertigo—Doxorubicin—pancreatic cancer	0.000183	0.000778	CcSEcCtD
Danazol—Syncope—Doxorubicin—pancreatic cancer	0.000182	0.000776	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—pancreatic cancer	0.000182	0.000775	CcSEcCtD
Danazol—Palpitations—Doxorubicin—pancreatic cancer	0.00018	0.000765	CcSEcCtD
Danazol—Oedema—Epirubicin—pancreatic cancer	0.000179	0.000763	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000179	0.000761	CcSEcCtD
Danazol—Shock—Epirubicin—pancreatic cancer	0.000176	0.000751	CcSEcCtD
Danazol—Convulsion—Doxorubicin—pancreatic cancer	0.000176	0.00075	CcSEcCtD
Danazol—Dizziness—Docetaxel—pancreatic cancer	0.000176	0.000749	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000175	0.000748	CcSEcCtD
Danazol—Hypertension—Doxorubicin—pancreatic cancer	0.000175	0.000747	CcSEcCtD
Danazol—Tachycardia—Epirubicin—pancreatic cancer	0.000175	0.000745	CcSEcCtD
Danazol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000173	0.000738	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—pancreatic cancer	0.000173	0.000737	CcSEcCtD
Danazol—Anxiety—Doxorubicin—pancreatic cancer	0.000172	0.000734	CcSEcCtD
Danazol—Vomiting—Docetaxel—pancreatic cancer	0.000169	0.00072	CcSEcCtD
Danazol—Rash—Docetaxel—pancreatic cancer	0.000168	0.000714	CcSEcCtD
Danazol—Dermatitis—Docetaxel—pancreatic cancer	0.000167	0.000713	CcSEcCtD
Danazol—Headache—Docetaxel—pancreatic cancer	0.000166	0.000709	CcSEcCtD
Danazol—Oedema—Doxorubicin—pancreatic cancer	0.000166	0.000706	CcSEcCtD
Danazol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000163	0.000696	CcSEcCtD
Danazol—Shock—Doxorubicin—pancreatic cancer	0.000163	0.000695	CcSEcCtD
Danazol—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000162	0.000692	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—pancreatic cancer	0.000162	0.000689	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—pancreatic cancer	0.000161	0.000686	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00016	0.000683	CcSEcCtD
Danazol—Nausea—Docetaxel—pancreatic cancer	0.000158	0.000672	CcSEcCtD
Danazol—Dyspepsia—Epirubicin—pancreatic cancer	0.000158	0.000672	CcSEcCtD
Danazol—Fatigue—Epirubicin—pancreatic cancer	0.000155	0.000658	CcSEcCtD
Danazol—Constipation—Epirubicin—pancreatic cancer	0.000153	0.000653	CcSEcCtD
Danazol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000151	0.000644	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000149	0.000634	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000146	0.000622	CcSEcCtD
Danazol—Fatigue—Doxorubicin—pancreatic cancer	0.000143	0.000609	CcSEcCtD
Danazol—Urticaria—Epirubicin—pancreatic cancer	0.000142	0.000607	CcSEcCtD
Danazol—Constipation—Doxorubicin—pancreatic cancer	0.000142	0.000604	CcSEcCtD
Danazol—Body temperature increased—Epirubicin—pancreatic cancer	0.000142	0.000604	CcSEcCtD
Danazol—Urticaria—Doxorubicin—pancreatic cancer	0.000132	0.000561	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000131	0.000558	CcSEcCtD
Danazol—Asthenia—Epirubicin—pancreatic cancer	0.000129	0.000548	CcSEcCtD
Danazol—Pruritus—Epirubicin—pancreatic cancer	0.000127	0.00054	CcSEcCtD
Danazol—Asthenia—Doxorubicin—pancreatic cancer	0.000119	0.000507	CcSEcCtD
Danazol—Dizziness—Epirubicin—pancreatic cancer	0.000119	0.000505	CcSEcCtD
Danazol—Pruritus—Doxorubicin—pancreatic cancer	0.000117	0.0005	CcSEcCtD
Danazol—Vomiting—Epirubicin—pancreatic cancer	0.000114	0.000485	CcSEcCtD
Danazol—Rash—Epirubicin—pancreatic cancer	0.000113	0.000481	CcSEcCtD
Danazol—Dermatitis—Epirubicin—pancreatic cancer	0.000113	0.000481	CcSEcCtD
Danazol—Headache—Epirubicin—pancreatic cancer	0.000112	0.000478	CcSEcCtD
Danazol—Dizziness—Doxorubicin—pancreatic cancer	0.00011	0.000467	CcSEcCtD
Danazol—Nausea—Epirubicin—pancreatic cancer	0.000106	0.000453	CcSEcCtD
Danazol—Vomiting—Doxorubicin—pancreatic cancer	0.000105	0.000449	CcSEcCtD
Danazol—Rash—Doxorubicin—pancreatic cancer	0.000105	0.000445	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—pancreatic cancer	0.000104	0.000445	CcSEcCtD
Danazol—Headache—Doxorubicin—pancreatic cancer	0.000104	0.000443	CcSEcCtD
Danazol—Nausea—Doxorubicin—pancreatic cancer	9.85e-05	0.00042	CcSEcCtD
Danazol—AR—Gene Expression—HSPA1A—pancreatic cancer	5.09e-05	0.000221	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.06e-05	0.000219	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SSTR1—pancreatic cancer	5.04e-05	0.000218	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPY—pancreatic cancer	4.95e-05	0.000214	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL8—pancreatic cancer	4.92e-05	0.000213	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HIF1A—pancreatic cancer	4.9e-05	0.000212	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TSC2—pancreatic cancer	4.89e-05	0.000212	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—pancreatic cancer	4.88e-05	0.000211	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH4—pancreatic cancer	4.87e-05	0.000211	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.86e-05	0.00021	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SSTR2—pancreatic cancer	4.86e-05	0.00021	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	4.84e-05	0.000209	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.82e-05	0.000209	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—pancreatic cancer	4.79e-05	0.000207	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.78e-05	0.000207	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	4.78e-05	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GLP1R—pancreatic cancer	4.75e-05	0.000206	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SST—pancreatic cancer	4.71e-05	0.000204	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KDR—pancreatic cancer	4.69e-05	0.000203	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TERT—pancreatic cancer	4.69e-05	0.000203	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCKBR—pancreatic cancer	4.69e-05	0.000203	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DPYD—pancreatic cancer	4.67e-05	0.000202	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.66e-05	0.000202	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPA1B—pancreatic cancer	4.65e-05	0.000201	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JAG1—pancreatic cancer	4.61e-05	0.0002	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	4.59e-05	0.000199	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—pancreatic cancer	4.51e-05	0.000195	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HIF1A—pancreatic cancer	4.48e-05	0.000194	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TSC2—pancreatic cancer	4.47e-05	0.000194	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NFKBIA—pancreatic cancer	4.46e-05	0.000193	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	4.43e-05	0.000192	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOTCH1—pancreatic cancer	4.42e-05	0.000191	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DTX4—pancreatic cancer	4.41e-05	0.000191	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GLI1—pancreatic cancer	4.41e-05	0.000191	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.39e-05	0.00019	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.39e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	4.38e-05	0.00019	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—pancreatic cancer	4.38e-05	0.00019	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CNR1—pancreatic cancer	4.35e-05	0.000188	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	4.33e-05	0.000188	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CG—pancreatic cancer	4.32e-05	0.000187	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—NRAS—pancreatic cancer	4.32e-05	0.000187	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—pancreatic cancer	4.31e-05	0.000187	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRP1—pancreatic cancer	4.29e-05	0.000186	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP2R5B—pancreatic cancer	4.29e-05	0.000186	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KDR—pancreatic cancer	4.29e-05	0.000186	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGF—pancreatic cancer	4.27e-05	0.000185	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.25e-05	0.000184	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.23e-05	0.000183	CbGpPWpGaD
Danazol—ESR1—Gene Expression—EZH2—pancreatic cancer	4.23e-05	0.000183	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GCG—pancreatic cancer	4.2e-05	0.000182	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH3—pancreatic cancer	4.14e-05	0.000179	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HEY2—pancreatic cancer	4.13e-05	0.000179	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NFKBIA—pancreatic cancer	4.08e-05	0.000177	CbGpPWpGaD
Danazol—AR—Gene Expression—SMAD4—pancreatic cancer	4.05e-05	0.000175	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH1—pancreatic cancer	4.04e-05	0.000175	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAST—pancreatic cancer	4.03e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AGTR1—pancreatic cancer	4e-05	0.000173	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CG—pancreatic cancer	3.95e-05	0.000171	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—NRAS—pancreatic cancer	3.95e-05	0.000171	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STK11—pancreatic cancer	3.95e-05	0.000171	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—pancreatic cancer	3.94e-05	0.00017	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPA1A—pancreatic cancer	3.92e-05	0.00017	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH1—pancreatic cancer	3.92e-05	0.00017	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGF—pancreatic cancer	3.91e-05	0.000169	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.86e-05	0.000167	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SCT—pancreatic cancer	3.82e-05	0.000166	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HEY1—pancreatic cancer	3.82e-05	0.000166	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CD—pancreatic cancer	3.8e-05	0.000164	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—KRAS—pancreatic cancer	3.72e-05	0.000161	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—pancreatic cancer	3.7e-05	0.00016	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCK—pancreatic cancer	3.65e-05	0.000158	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—pancreatic cancer	3.6e-05	0.000156	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.59e-05	0.000155	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CNR2—pancreatic cancer	3.55e-05	0.000154	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GLP1R—pancreatic cancer	3.55e-05	0.000154	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCKAR—pancreatic cancer	3.5e-05	0.000151	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CD—pancreatic cancer	3.47e-05	0.00015	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SMAD4—pancreatic cancer	3.46e-05	0.00015	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.44e-05	0.000149	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CD44—pancreatic cancer	3.43e-05	0.000149	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.42e-05	0.000148	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—KRAS—pancreatic cancer	3.4e-05	0.000147	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JAG2—pancreatic cancer	3.39e-05	0.000147	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HES1—pancreatic cancer	3.37e-05	0.000146	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.36e-05	0.000146	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MEN1—pancreatic cancer	3.34e-05	0.000145	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MYC—pancreatic cancer	3.34e-05	0.000144	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.33e-05	0.000144	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CB—pancreatic cancer	3.31e-05	0.000143	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GCG—pancreatic cancer	3.29e-05	0.000143	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SHH—pancreatic cancer	3.19e-05	0.000138	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—pancreatic cancer	3.18e-05	0.000138	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH4—pancreatic cancer	3.17e-05	0.000137	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—pancreatic cancer	3.16e-05	0.000137	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IAPP—pancreatic cancer	3.15e-05	0.000136	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—pancreatic cancer	3.12e-05	0.000135	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SMAD4—pancreatic cancer	3.12e-05	0.000135	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—STK11—pancreatic cancer	3.09e-05	0.000134	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—pancreatic cancer	3.04e-05	0.000132	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CB—pancreatic cancer	3.03e-05	0.000131	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTHLH—pancreatic cancer	3.02e-05	0.000131	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTCH1—pancreatic cancer	3.02e-05	0.000131	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH1—pancreatic cancer	2.99e-05	0.000129	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—pancreatic cancer	2.96e-05	0.000128	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TERT—pancreatic cancer	2.96e-05	0.000128	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—pancreatic cancer	2.93e-05	0.000127	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—pancreatic cancer	2.91e-05	0.000126	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.9e-05	0.000126	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—pancreatic cancer	2.89e-05	0.000125	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MMP9—pancreatic cancer	2.88e-05	0.000125	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—pancreatic cancer	2.86e-05	0.000124	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HIF1A—pancreatic cancer	2.83e-05	0.000122	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC2—pancreatic cancer	2.82e-05	0.000122	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—pancreatic cancer	2.82e-05	0.000122	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—pancreatic cancer	2.81e-05	0.000122	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—pancreatic cancer	2.79e-05	0.000121	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—pancreatic cancer	2.78e-05	0.000121	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SST—pancreatic cancer	2.76e-05	0.00012	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—pancreatic cancer	2.76e-05	0.00012	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—pancreatic cancer	2.71e-05	0.000117	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JAG1—pancreatic cancer	2.7e-05	0.000117	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KDR—pancreatic cancer	2.7e-05	0.000117	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH3—pancreatic cancer	2.69e-05	0.000117	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—pancreatic cancer	2.68e-05	0.000116	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMS—pancreatic cancer	2.66e-05	0.000115	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—pancreatic cancer	2.65e-05	0.000115	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—pancreatic cancer	2.63e-05	0.000114	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—pancreatic cancer	2.62e-05	0.000113	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—pancreatic cancer	2.58e-05	0.000112	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	2.57e-05	0.000111	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—pancreatic cancer	2.57e-05	0.000111	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—pancreatic cancer	2.56e-05	0.000111	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—pancreatic cancer	2.55e-05	0.000111	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRAS—pancreatic cancer	2.55e-05	0.000111	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CNR1—pancreatic cancer	2.55e-05	0.00011	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	2.55e-05	0.00011	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	2.49e-05	0.000108	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GCG—pancreatic cancer	2.46e-05	0.000107	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGF—pancreatic cancer	2.46e-05	0.000107	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—pancreatic cancer	2.43e-05	0.000105	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—pancreatic cancer	2.38e-05	0.000103	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—pancreatic cancer	2.37e-05	0.000103	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—pancreatic cancer	2.36e-05	0.000102	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGTR1—pancreatic cancer	2.35e-05	0.000102	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—pancreatic cancer	2.34e-05	0.000101	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRAS—pancreatic cancer	2.33e-05	0.000101	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—pancreatic cancer	2.32e-05	0.000101	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STK11—pancreatic cancer	2.32e-05	0.0001	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH1—pancreatic cancer	2.3e-05	9.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.27e-05	9.82e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—pancreatic cancer	2.2e-05	9.51e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	2.19e-05	9.49e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—pancreatic cancer	2.17e-05	9.41e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—pancreatic cancer	2.17e-05	9.4e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—pancreatic cancer	2.17e-05	9.39e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—pancreatic cancer	2.16e-05	9.37e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—pancreatic cancer	2.13e-05	9.21e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—pancreatic cancer	2.11e-05	9.13e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.05e-05	8.87e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SMAD4—pancreatic cancer	2.03e-05	8.78e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—pancreatic cancer	2.02e-05	8.74e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—pancreatic cancer	2.01e-05	8.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HES1—pancreatic cancer	1.98e-05	8.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.97e-05	8.52e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	1.95e-05	8.46e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—pancreatic cancer	1.95e-05	8.45e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	1.91e-05	8.27e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—pancreatic cancer	1.89e-05	8.16e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—pancreatic cancer	1.87e-05	8.08e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—pancreatic cancer	1.85e-05	7.99e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—pancreatic cancer	1.83e-05	7.94e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—pancreatic cancer	1.79e-05	7.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—pancreatic cancer	1.76e-05	7.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TERT—pancreatic cancer	1.74e-05	7.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.72e-05	7.44e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	1.72e-05	7.44e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—pancreatic cancer	1.71e-05	7.4e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—pancreatic cancer	1.71e-05	7.39e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	1.69e-05	7.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HIF1A—pancreatic cancer	1.66e-05	7.19e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—pancreatic cancer	1.66e-05	7.19e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC2—pancreatic cancer	1.66e-05	7.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—pancreatic cancer	1.65e-05	7.14e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—pancreatic cancer	1.65e-05	7.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—pancreatic cancer	1.62e-05	7.02e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—pancreatic cancer	1.61e-05	6.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KDR—pancreatic cancer	1.59e-05	6.87e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—pancreatic cancer	1.53e-05	6.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKBIA—pancreatic cancer	1.51e-05	6.54e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—pancreatic cancer	1.51e-05	6.53e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	1.5e-05	6.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH1—pancreatic cancer	1.5e-05	6.48e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—pancreatic cancer	1.49e-05	6.45e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—pancreatic cancer	1.48e-05	6.42e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—pancreatic cancer	1.48e-05	6.39e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRAS—pancreatic cancer	1.47e-05	6.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—pancreatic cancer	1.46e-05	6.33e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—pancreatic cancer	1.46e-05	6.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGF—pancreatic cancer	1.45e-05	6.26e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.39e-05	6e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—pancreatic cancer	1.37e-05	5.94e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—pancreatic cancer	1.37e-05	5.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.36e-05	5.9e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—pancreatic cancer	1.34e-05	5.81e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.29e-05	5.6e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—pancreatic cancer	1.29e-05	5.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CD—pancreatic cancer	1.29e-05	5.57e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—pancreatic cancer	1.27e-05	5.49e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—pancreatic cancer	1.24e-05	5.36e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	1.16e-05	5.04e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—pancreatic cancer	1.13e-05	4.88e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.12e-05	4.85e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—pancreatic cancer	1.11e-05	4.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—pancreatic cancer	1.08e-05	4.66e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—pancreatic cancer	1.08e-05	4.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—pancreatic cancer	1.03e-05	4.46e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—pancreatic cancer	1e-05	4.34e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD44—pancreatic cancer	1e-05	4.34e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—pancreatic cancer	9.93e-06	4.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—pancreatic cancer	9.74e-06	4.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—pancreatic cancer	9.68e-06	4.19e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCG—pancreatic cancer	9.6e-06	4.16e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—pancreatic cancer	9.51e-06	4.12e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	9.12e-06	3.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STK11—pancreatic cancer	9.03e-06	3.91e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—pancreatic cancer	8.98e-06	3.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—pancreatic cancer	8.74e-06	3.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—pancreatic cancer	8.66e-06	3.75e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRAS—pancreatic cancer	8.64e-06	3.74e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—pancreatic cancer	8.58e-06	3.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—pancreatic cancer	8.05e-06	3.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—pancreatic cancer	8.03e-06	3.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—pancreatic cancer	7.87e-06	3.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.77e-06	3.36e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—pancreatic cancer	7.45e-06	3.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—pancreatic cancer	7.43e-06	3.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—pancreatic cancer	6.83e-06	2.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—pancreatic cancer	6.61e-06	2.86e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—pancreatic cancer	6.32e-06	2.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—pancreatic cancer	6.32e-06	2.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.7e-06	2.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—pancreatic cancer	5.58e-06	2.42e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.5e-06	2.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	5.01e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.37e-06	1.89e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.33e-06	1.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.77e-06	1.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.66e-06	1.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.18e-06	9.42e-06	CbGpPWpGaD
